Qiagen and National Cancer Institute, Illumina and Burnham Institute, Innovative Biosensors, South Korea, GE Healthcare, and Analytik Jena and Biozym Scientific | GenomeWeb

Qiagen and NCI to Develop siRNAs for Cancer Research

Qiagen and the National Cancer Institute will co-develop and validate a set of siRNAs for cancer genes for use by NCI researchers, Qiagen said this week.

The validated siRNA set will be made available to the general research community following the characterization project, Qiagen said.

Financial terms of the deal were not disclosed.

Illumina, Burnham Institute Will Soon Publish BeadChip Study of Embryonic Stem Cells

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.